Excelsior Medical Co., Ltd. · TWSE:4104

Excelsior Medical — H1 2020 Earnings Presentation

33 slides from Excelsior Medical's earnings presentation, 2020

  1. Slide 1: Excelsior Medical Co., Ltd. 2020 H1 Investor Conference

    Excelsior Medical Co., Ltd. 2020 H1 Investor Conference

  2. Slide 2: Disclaimer

    Disclaimer This presentation is prepared according to the reviewed financial statements by CPA and the financial figures hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ materially f

  3. Slide 3: Table of Contents

    Table of Contents 1.公司概況(Corporate Overview) P.4 2.市場概況(Market Overview) P.8 3.營運概況(Business Overview) P.11 4.財務概況(Financial Overview) P.14 5.轉投資概況(Investment Overview) P.17 6.2020策略及展望(2020 Strategies and Outlook) P.23 7.補充資料(Appendix) P.26 3

  4. Slide 4: Corporate Overview

    Corporate Overview Chairman Group President Tony Fu “Dedication, Discipline, Innovation, Proactive” are the core values of Excelsior . “Human Healthcare” is the basis of medical service industry. Therefore, “Dedication” to our service target is what matters the most. We focus on public healthcare, u

  5. Slide 5: The Most Valuable Total Healthcare Solution Provider among Asia

    The Most Valuable Total Healthcare Solution Provider among Asia with Exceptional Investment and Operating Teams! Excelsior Medical Co.,Ltd. was founded in 1988,Excelsior started with the distribution of hemodialysis equipments and supplies . Gradually transformed into medical services integration ch

  6. Slide 6: Revenue structure

    Revenue structure Excelsior yearly consolidated sales is more than NT $ 6 billion, the primary revenue comes from Excelsior(Hemodialysis), Dynamic(Medical Aesthetic), Arich (Pharmaceutical Logistics) and others. According to the company’s function ,the business type can be characterized as trading b

  7. Slide 7: The Business Types

    The Business Types Hemodialysis Medical Aesthetic Trading Business Medical Equipment Medical Consumables Home Appliance Product Planning Sales Information Analysis Promotion Hemodialysis channel Medical Information System Market Creative Medical Aesthetic channel Pharmaceutical Distribution Manageme

  8. Slide 8: Market Overview

    Market Overview Excelsior(Hemodialysis) Taiwan benefited from the implementation of the national health insurance system in 1995 and the hemodialysis technology and quality gradually mature, the patient's survival rate has gradually increased. According to National Kidney Foundation R.O.C statistics

  9. Slide 9: Dynamic (Medical Aesthetic)

    Dynamic(Medical Aesthetic) According to the Asian-Pacific Market Study issued by Medical Insight, Inc. in Feb. 2020, total Asian sales of all aesthetic products and equipment reached USD $2.6 billion in 2018 and are expected to increase by 10.0% per year through 2023. Furthermore, medical aesthetic

  10. Slide 10: Arich (Pharmaceutical Logistics)

    Arich (Pharmaceutical Logistics) Pharmaceuticals cost approximately 1/4 of National Health Insurance expenditures. In Taiwan, although demand for medication is growing, but the prices approved/reimbursed by NHI are declining. Consequently the multinational pharmaceutical companies keep on outsourcin

  11. Slide 11: Business Overview: Excelsior (Hemodialysis)

    Business Overview Excelsior(Hemodialysis) Excelsior’s operating incomes were NT $ Units: NTD in thousands 263,303 (NTD in thousands) in 2019 and NT $ 279,606 (NTD in thousands) in 2018; the growth rate was -5.8%. The greater operating income in 2020 H1 than which of 2019 H1 is mainly because of grea

  12. Slide 12: Dynamic (Medical Aesthetic)

    Dynamic(Medical Aesthetic) Units: NTD in thousands Operating income were $ 157,823 (NTD in thousands) in 2019 and $ 133,005 (NTD in thousands) in 2018, due to deduction of marketing expenses of Dynamic Taiwan and deduction of operating expenses from downsizing of oversea subsidiaries. Operating Inco

  13. Slide 13: Arich (Pharmaceutical Logistics)

    Arich (pharmaceutical logistics) Units: NTD in thousands Operating income were NT$ 65,522 thousand dollars in 2019 and NT$ 46,410 thousand dollars in 2018, because there were deductions of operating expenses. Operating income of 2020 H1 is slightly less than which of 2019 H1 because of increasing sa

  14. Slide 14: Financial Overview

    Financial Overview Consolidated gross profit Consolidated sales Units: NTD in thousands Units: NTD in thousands Consolidated operating income Units: NTD in thousands 14

  15. Slide 15: Units: NTD in thousands Units: NTD in thousands

    Units: NTD in thousands Units: NTD in thousands 15

  16. Slide 16: Units: NTD in thousands Units : NTD in Dollars

    Units : NTD in Dollars Units: NTD in thousands 16

  17. Slide 17: Investment Overview: Hemodialysis channel

    Investment Overview Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd 【 Hemodialysis channel Introduction 】 Excelsior entered into a joint venture with Fresenius which is the world's largest manufacturer of dialysis products, and establishes long-term cooperative

  18. Slide 18: Hemodialysis channel – Excelsior Renal Service

    Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd Units : except ERS channels, NTD in thousands 18

  19. Slide 19: Hemodialysis channels

    Total % Area ERS channels channels Taipei:20 keelong:3 North 267 33 12.4% Central 197 46 23.4% South 194 21 10.8% other 38 1 2.6% Total 696 101 14.5% Taoyuan:8 Hsinchu:2 Miaoli:2 Taichung:27 Changhua:7 Yilan :1 Yunlin:2 Nantou:6 Chiayi:2 Tainan:9 pingtung:4 Kaohsiung:8 Hemodialysis channels 19

  20. Slide 20: Long-Term Care Channels– Asia Best Healthcare Co., Ltd.

    Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Xi-zhi Nursing Home 內部配置 【 Long-Term Care Channels Introduction 】 Excelsior combines the experiences and advantages in medical industry, with innovative concepts to build higher service standards of long-term care channels. We provide Long Term

  21. Slide 21: Long-Term Care Channels– Asia Best Healthcare Co., Ltd.

    Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Units:except ABH Beds, NTD in thousands 招大廳 21

  22. Slide 22: Long-term care channels

    Hospital/long-term care Hospital Beds 532 Long-term care channels Long-term care 2,732 Total 3,264 keelong:114 beds Xizhi Taoyuan : 204 beds Taipei:165 beds Ping- zhen New Taipei City: 1,292 beds Taichung:581 beds Tai -chung Changhua: 200 beds Yunlin :131 beds Kaoh -siung Nantou :294 beds Tainan :99

  23. Slide 23: 2020 Strategies and Outlook

    2020 Strategies and Outlook Excelsior(Hemodialysis) Long-Term Planning Mid-Term Planning Excelsior develops from Taiwan to Asia , and follows government’s direction “The 1.Integrating upstream and New Southbound Policy ”, we downstream medical resources , will proceed to focus on increasing business

  24. Slide 24: Dynamic (Medical Aesthetic)

    Dynamic(Medical Aesthetic) Long-Term Planning  To target aesthetic Mid-Term Planning medicine product in  Launch of Build Muscle market  Launch of Neurotoxins  Aesthetic medicine distributor in Southeast Asia  Integrate aesthetic Short-Term Plan competitor and Channel  Multiple micro-plastic s

  25. Slide 25: Arich (pharmaceutical logistics)

    Arich (pharmaceutical logistics) Long-Term Planning 1.Sales Revenue Mid-Term Planning A.To seek strategic partners and to expand the variety of our 1.Sales Revenue products. A.Medication:To increase B.To integrate excelsior group’s our product items. dialysis and long term care B.Dementia medication

  26. Slide 26: Appendix: Balance Sheet

    wes Appendix Balance Sheet Units: In thousands NTD | 2018.12.31 | 2019.12.31 | ~—_—-2020.06.30 Assets |CurrentAssets Cash and Cash Equivalents 3,100,081 2,828,776 2,827,371 1,605,261 1,561,835 1,533,393 Other Receivables 3,765,675 2,687,002 2,366,646 |_inventories 1,008,284 853,185 863,302 Other Cur

  27. Slide 27: Balance Sheet

    Balance Sheet |Units:In thousands NTDC“‘CNCCOC*LSC 2018.12.31 [| 2019.12.31 | 2020.06.30 | 1,110,000 1,212,967 304,000 1,014,679 1,059,278 888,289 2,498,680 1,809,771 2,283,969 482,617 747,086 667,470 5,105,976 4,829,102 4,143,728 z 644 z 532,491 303,326 403,835 532,491 303,970 403,835 5,638,467 5,1

  28. Slide 28: Statement of Comprehensive Income

    Statement of Comprehensive Income 28

  29. Slide 29: Statements of Cash Flows

    oe] Bee i | i Units: In thousands NTD Profit before income tax Adjustments items Cash flows from operating Activities Receivable (increase) decrease Other Receivable (increase) decrease Inventories (increase) decrease Payable increase (decrease Other Payable increase (decrease Income tax paid Net ca

  30. Slide 30: Statements of Cash Flows

    Exceinior Healtncare Groep oe] Seo Statements of Cash Flows Units: In thousands NTD P2018 T2019 20201 Cash flows from investing activities Purchase of financial assets at amortized cost (1,027,056) Proceeds from disposal of financial assets at : 1,716,236 amortized cost Acquisition of investments ac

  31. Slide 31: Statements of Cash Flows: Financing Activities

    Units: In thousands NTD ash flows from financing Activities Increase (decrease) in short-term loans Repayments of bonds Repayments of long-term loans Dividends paid to owners of the Company Partial acquisition of interests in subsidiaries Proceeds from issue of ordinary shares Net cash used in finan

  32. Slide 32: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China

  33. Slide 33: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China

Excelsior Medical — H1 2020 Earnings Presentation on 6ix